Literature DB >> 31256684

Acute angle-closure glaucoma with choroidal effusion revealing a hantavirus infection: Description of ultrasound biomicroscopy imagery and optical coherence tomography Visante.

Alexandre Baillieul1, Tich Ludovic Le1, Jean-François Rouland1.   

Abstract

PURPOSE: To report a case of bilateral angle-closure associated with systemic hantavirus infection.
MATERIALS AND METHODS: A 32-year-old Caucasian man was referred with blurred vision, fever, cough, dyspnea and thrombocytopenia. Ophthalmologic examination revealed myopic shift, elevated intraocular pressure (30 mmHg right eye and 24 mmHg left eye), corneal edema, iridocorneal angle closure and shallow anterior chamber. Ciliochoroidal effusion was detected on anterior segment optical coherence tomography and ultrasound biomicroscopy. Serologic test and polymerase chain reaction confirmed the diagnosis of hantavirus infection and the serotype Puumala. On the sixth day after he started topical anti-glaucoma and cycloplegic medications, the anterior chamber and iridocorneal angles were normalized with disappearance of ciliochoroidal effusion.
CONCLUSION: Puumala hantavirus infection is an exceptional cause of acute bilateral angle-closure combined with ciliochoroidal effusion.

Entities:  

Keywords:  Glaucoma; Puumala; choroidal effusion; hantavirus

Mesh:

Substances:

Year:  2019        PMID: 31256684     DOI: 10.1177/1120672119858895

Source DB:  PubMed          Journal:  Eur J Ophthalmol        ISSN: 1120-6721            Impact factor:   2.597


  2 in total

Review 1.  Ocular manifestations of emerging viral diseases.

Authors:  Ashwin Venkatesh; Ravi Patel; Simran Goyal; Timothy Rajaratnam; Anant Sharma; Parwez Hossain
Journal:  Eye (Lond)       Date:  2021-01-29       Impact factor: 3.775

Review 2.  Central Nervous System and Ocular Manifestations in Puumala Hantavirus Infection.

Authors:  Nina Hautala; Terhi Partanen; Anna-Maria Kubin; Heikki Kauma; Timo Hautala
Journal:  Viruses       Date:  2021-05-31       Impact factor: 5.048

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.